Results 321 to 330 of about 13,086,034 (342)
Some of the next articles are maybe not open access.

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

Nature Medicine, 2015
Husain Attarwala   +2 more
exaly  

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

New England Journal of Medicine, 2007
Sharon Funk Dpt   +2 more
exaly  

CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice

Human Genetics, 2017
C. Huai   +8 more
semanticscholar   +1 more source

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Journal of Thrombosis and Haemostasis, 2015
P Chowdary
exaly  

Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia

Nature Communications, 2020
Dongli Wang   +2 more
exaly  

CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs

International journal of hematology, 2019
Satoshi Morishige   +11 more
semanticscholar   +1 more source

Update on clinical gene therapy for hemophilia

Blood, 2019
Roland W Herzog, David M Markusic
exaly  

Molecular Biology of Hemophilia B

Thrombosis and Haemostasis, 1993
openaire   +2 more sources

Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: Validity of the hemophilia joint health score

Arthritis Care and Research, 2011
Brian M Feldman   +2 more
exaly  

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

Blood, 2007
Jan Astermark   +2 more
exaly  
medicine
biology
factor ix
gene
genetics
internal medicine
immunology
genetic enhancement
recombinant dna
previous   31  32  33  34  35  

Home - About - Disclaimer - Privacy